124.552  Information reporting.
  1.  Unless otherwise prohibited by federal or state law, each licensed pharmacy that dispenses controlled substances identified pursuant to section 124.554, subsection 1, paragraph “g”, to patients in the state, each licensed pharmacy located in the state that dispenses such controlled substances identified pursuant to section 124.554, subsection 1, paragraph “g”, to patients inside or outside the state, unless specifically excepted in this section or by rule, and each prescribing practitioner furnishing, dispensing, or supplying controlled substances to the prescribing practitioner’s patient, shall submit the following prescription information to the program:
  a.  Pharmacy identification.
  b.  Patient identification.
  c.  Prescribing practitioner identification.
  d.  The date the prescription was issued by the prescribing practitioner.
  e.  The date the prescription was dispensed.
  f.  An indication of whether the prescription dispensed is new or a refill.
  g.  Identification of the drug dispensed.
  h.  Quantity of the drug dispensed.
  i.  The number of days’ supply of the drug dispensed.
  j.  Serial or prescription number assigned by the pharmacy.
  k.  Type of payment for the prescription.
  l.  Other information identified by the board by rule.
  2.  Information shall be submitted electronically in a secure format specified by the board unless the board has granted a waiver and approved an alternate secure format.
  3.  Information shall be timely transmitted within one business day of the dispensing of the controlled substance, unless the board grants an extension. The board may grant an extension if either of the following occurs:
  a.  The pharmacy or prescribing practitioner suffers a mechanical or electronic failure, or cannot meet the deadline established by the board for other reasons beyond the pharmacy’s or practitioner’s control.
  b.  The board is unable to receive electronic submissions.
  4.  This section shall not apply to dispensing by a licensed pharmacy for the purposes of inpatient hospice care or long-term residential facility patient care.
2006 Acts, ch 1147, §3, 11; 2007 Acts, ch 126, §25, 26; 2018 Acts, ch 1138, §5